Your browser doesn't support javascript.
Treatment with obinutuzumab leads to worse outcomes in haematological patients diagnosed with Omicron variant COVID-19.
Shafat, Tali; Grupel, Daniel; Porges, Tzvika; Levi, Itai; Yagel, Yael; Nesher, Lior.
  • Shafat T; Infectious Diseases Institute, Soroka University Medical Center, and the faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Grupel D; Clinical Research Center, Soroka University Medical Center, and the faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Porges T; Infectious Diseases Institute, Soroka University Medical Center, and the faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Levi I; Haematology Department, Soroka University Medical Center, and the faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Yagel Y; Haematology Department, Soroka University Medical Center, and the faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
  • Nesher L; Infectious Diseases Institute, Soroka University Medical Center, and the faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Br J Haematol ; 198(5): 826-829, 2022 09.
Article in English | MEDLINE | ID: covidwho-1895956
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Topics: Variants Limits: Humans Language: English Journal: Br J Haematol Year: 2022 Document Type: Article Affiliation country: Bjh.18315

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Topics: Variants Limits: Humans Language: English Journal: Br J Haematol Year: 2022 Document Type: Article Affiliation country: Bjh.18315